Aaron Dexter

Mr. Aaron Dexter

Pharmacology, University of Cambridge, Cambridge, Cambridgeshire, UK
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2023 in Cells
Verified
Journal Article
Open access
PDF file
RNRichard Teke Ngomba
Richard Teke Ngomba
ALAnnika Lüttjohann
Annika Lüttjohann
ADAaron Dexter
Aaron Dexter
Swagat RaySwagat Ray
Swagat Ray
GLGilles van Luijtelaar
Gilles van Luijtelaar
Sleep is an essential innate but complex behaviour which is ubiquitous in the animal kingdom. Our knowledge of the distinct neural circuit mechanisms that regulate sleep and wake states in the brain are, however, still limited. It is therefore important to understand how these circuits operate during health and disease. This review will highlight the function of mGlu5 receptors within the thalamocortical circuitry in physiological and pathological sleep states. We will also evaluate the potential of targeting mGlu5 receptors as a therapeutic strategy for sleep disorders that often co-occur with epileptic seizures.

14 May 2026 in ACS Omega
Verified
Journal Article
Open access
KGKyriakos Georgiou
Kyriakos Georgiou
MLMaria Lamprakopoulou
Maria Lamprakopoulou
HBHannes Buthmann
Hannes Buthmann
SBSabrina Böing
Sabrina Böing
APAthanasios Pousias
Athanasios Pousias
NLNikolaos Lougiakis
Nikolaos Lougiakis
This study aimed to improve the adenosine receptor (AR) subtype selectivity of the previously reported 7-benzylamino-1-methyl-3-phenyl-pyrazolo­[3,4-d]­pyridazine analogue PPZ I, a nanomolar dual nonselective adenosine hA1/hA3 receptor antagonist (Ki = 11 nM hA1R/13 nM hA3R). To this end, 31 novel derivatives bearing the pyrazolo­[4,3-d]­pyrimidine scaffold were designed and synthesized, incorporating either 7-benzylamino or 7-phenylamino substituents. Binding affinities were determined using a bioluminescence resonance energy transfer assay against hA1R and hA3R, alongside functional characterization of antagonistic activity and selectivity across all four AR subtypes. These studies identified compounds 9 and 40 as the most promising derivatives in the series. Compound 9 exhibited approximately 4-fold selectivity for hA1R over hA3R, whereas compound 40 showed a 10-fold preference for hA3R over hA1R. Both compounds displayed low-affinity binding to the two hA2R subtypes, which was more significant against hA2AR. Overall, compounds 9 and 40 exhibited up to 3- and 6-fold selectivity for hA1R and hA3R, respectively, over the other hAR subtypes. Studies of the binding profile of 9 and 40 inside the orthosteric binding site of hA1R and hA3R showed that the pyrazole ring forming hydrogen bonding interactions with N6.55 was complemented using molecular dynamics simulations and relative binding free energy calculations and validated through site-directed mutagenesis. The findings of this study will lead to the design and synthesis of more effective compounds against hARs that may have a therapeutic effect against human diseases, such as glaucoma and asthma.

17 September 2025 in bioRxiv
Verified
Preprint
Open access
APAbigail Pearce
Abigail Pearce
MCMichael Collins
Michael Collins
ADAaron Dexter
Aaron Dexter
ASAnjana Saji
Anjana Saji
CSClaudia M Sisk
Claudia M Sisk
GLGraham Ladds
Graham Ladds
Animal use in research extends beyond the use of animal models to study physiology and disease. Many aspects of in vitro research use reagents derived from animals, most prolifically the use of foetal bovine serum (FBS) in growth media for cellular models. With the aim to reduce animal use, we investigated the effect of reduced FBS culture conditions on cell growth, as well as different stages of G protein-coupled receptor (GPCR) signalling, a wide area of research which might therefore impact many groups. We identified little differences on cell growth or GPCR signalling when reducing culture FBS percentage from 10% to 5%, using assays ranging from receptor activation to downstream transcription factors stimulation. In addition to diminishing animal use, the reduction of FBS use will also have economic and environmental benefits, which we hope will be of benefit to the wider research community.